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Growing evidence supports an association between attention-deficit/hyperactivity 
disorder (ADHD) and restless legs syndrome (RLS) in children.  Prior research suggests 
that in some patients iron deficiency is an underlying cause of pathological changes in the 
dopaminergic system of the brain that modulates these disorders. However, the 
underlying cause of such iron deficiency has not yet been identified.  We propose to 
determine the prevalence of low serum ferritin levels, a marker of reduced iron stores, in 
children with comorbid ADHD and RLS, and if diet is associated with their diagnosis and 
observed blood iron levels. A case-control study will examine a sample of 245 children 
with ADHD and 245 children without ADHD. We will use a diagnostic questionnaire to 
identify RLS in both groups, and dieticians will analyze 3-day food diaries to identify 
dietary iron intake. Our findings can inform clinicians of the importance of diet in the 












CHAPTER 1: INTRODUCTION 
1.1 Background  
Attention-deficit/hyperactivity disorder (ADHD) is the most common mental 
disorder diagnosed in children today.1 The worldwide pediatric prevalence of ADHD is 
estimated to be around 5%.2 However, according to the Centers for Disease Control and 
Prevention (CDC), approximately 11% of children ages 4-17 in the United States have 
been diagnosed with ADHD, with the average age of diagnosis at 7 years.3 ADHD is a 
neurodevelopmental disorder characterized by a persistent pattern of inattention and/or 
hyperactivity-impulsivity that interferes with functioning or development.2 The standard 
criteria used today to diagnose this disorder in the United States is the American 
Psychiatric Association’s Diagnostic and Statistical Manual of Mental Health Disorders, 
Fifth Edition (DSM-5), and there are multiple requirements that must be fulfilled in order 
to give a child this diagnosis.4 First, six or more symptoms of inattention and/or 
hyperactivity and impulsivity must be present for at least 6 months, and they must be 
developmentally inappropriate. Table 1 lists these symptoms.  
Symptoms of Inattention Symptoms of Hyperactivity and 
Impulsivity 
• Often fails to give close attention to 
details or makes careless mistakes in 
schoolwork, at work, or during other 
activities  
• Often has difficulty sustaining attention 
in tasks or play activities  
• Often does not seem to listen when 
spoken to directly  
• Often does not follow through on 
instructions and fails to finish 
schoolwork, chores, or duties in the 
workplace  
• Often fidgets with or taps hands or 
feet or squirms in seat 
• Often leaves seat in situations when 
remaining seated is expected  
• Often runs about or climbs in 
situations where it is inappropriate  
• Often unable to play or engage in 
leisure activities quietly 
• Is often “on the go,” acting as if 
“driven by a motor”  
• Often talks excessively 
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• Often has difficulty organizing tasks 
and activities 
• Often avoids, dislikes, or is reluctant to 
engage in tasks that require sustained 
mental effort  
• Often loses things necessary for tasks 
or activities  
• Is often easily distracted by extraneous 
stimuli  
• Is often forgetful in daily activities  
• Often blurts out an answer before a 
question has been completed  
• Often has difficulty waiting his or her 
turn 
• Often interrupts or intrudes on others  
 
Table 1. DSM-5 Symptom Criteria for ADHD.2 
In addition to this, four other conditions must be met: numerous symptoms of 
inattentiveness or hyperactivity/impulsivity must be present before the age of 12; they 
must be present in at least 2 settings (home, school, or work); they must interfere with 
social, academic, or occupational functioning; and lastly, these symptoms cannot develop 
exclusively with another psychotic disorder or be better explained by another mental 
disorder.2 
Once children are diagnosed with this disorder, health care providers usually 
recommend stimulant medication or behavior therapy as first line treatment to improve 
outcomes, depending on the age of the patient.5 For preschool aged children between 4 
and 5 years old, parent and teacher administered behavior therapy is first line treatment, 
whereas guidelines recommend stimulants for children older than 6 or for preschoolers in 
whom behavioral interventions do not provide improvement.6 Current stimulants 
available include short-, intermediate-, and long-acting methylphenidate or 
dextroamphetamine. Studies have shown that these treatments reduce core symptoms of 
inattention, hyperactivity, and impulsivity, as well as improve function in social and 
classroom domains.7 However, ADHD should be recognized as a chronic disease as 
medication is not curative, and it often persists into adulthood.6  
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Along with these daytime symptoms, parents of children with ADHD often report 
sleep issues in their children. The association of sleep problems and ADHD is a very 
close one, as 25% to 50% of children and adolescents with ADHD in clinical practice 
have difficulties initiating and maintaining sleep.8 Whereas adults usually exhibit 
excessive daytime sleepiness as a result of a poor night’s sleep, children often display the 
opposite.  They show signs of inattention, hyperactivity, and cognitive and behavioral 
dysfunction—those same symptoms recognized in ADHD.9 Given this relationship 
between ADHD and sleep alterations, clinicians began to look for an association between 
ADHD and restless legs syndrome (RLS), a particular dyssomnia that has been known to 
cause effects on daytime behavior in children.9  
RLS is a sensorimotor disorder that causes uncomfortable leg and arm sensations 
with an irresistible urge to move them.10 These sensations come at rest, and worsen 
during the evening or night.  In some people, they only occur at night. Those with RLS 
often have difficulty sleeping due to this unpleasant feeling in their legs.  It can delay 
sleep onset, awaken the individual from sleep, and cause significant sleep fragmentation.2 
This condition was not described until 1945, and the International Restless Legs 
Syndrome Study Group (IRLSSG) first established four diagnostic criteria for the 
uniform diagnosis of RLS in adults in 1995.11 The IRLSSG criteria were developed 
through a panel of international RLS clinical and research experts, and they have 
remained the fundamental criteria for diagnosing this disorder.12 Since 1995, these 
criteria have undergone two revisions, as RLS has gained more clinical exposure and has 
been further researched.12,13 A separate set of criteria was established in 2003 (and 
revised in 2013) for children aged 2-12 that required a verbal description of their 
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symptoms in their own age appropriate terminology.  This was added due to the fact that 
children often have a difficult time communicating the symptoms that they are feeling 
with RLS.14 The pediatric diagnostic criteria are a modified version of the adult criteria, 
separated into “definite,” “probable,” or “possible” RLS categories for research purposes. 
Adult criteria are difficult to determine in children who often spend prolonged periods of 
time seated in school. Table 2 lists the updated criteria. 
Diagnostic Criteria for RLS in Adults Diagnostic Criteria for RLS in Children 
1. An urge to move the legs, usually but 
not always accompanied by, or felt to 
be caused by, uncomfortable and 
unpleasant sensations in the legs. 
2. The urge to move the legs and any 
accompanying unpleasant sensations 
begin or worsen during periods of rest 
or inactivity such as lying down or 
sitting. 
3. The urge to move the legs and any 
accompanying unpleasant sensations 
are partially or totally relieved by 
movement, such as walking or 
stretching, at least as long as the 
activity continues.  
4. The urge to move the legs and any 
accompanying unpleasant sensations 
during rest or inactivity only occur or 
are worse in the evening or night than 
during the day. 
5. The occurrence of the above features 
is not solely accounted for as 
symptoms primary to another medical 
or a behavioral condition (e.g. 
myalgia, venous stasis, leg edema, 
arthritis, leg cramps, positional 
discomfort, habitual foot tapping). 
Specifiers for clinical course of RLS: 
A. Chronic-persistent: symptoms when 
not treated would occur on average at 
least twice weekly for the past year. 
Criteria for the diagnosis of definite 
RLS in children 
• The child meets all five essential adult 
criteria for RLS AND  
• The child relates a description in his or 
her own words that is consistent with 
leg discomfort (The child may use 
terms such as oowies, tickle, spiders, 
boo-boos, a lot of energy in my legs, 
need to move, want to move, and got 
to kick to describe symptoms.  Age-
appropriate descriptors are 
encouraged). 
Criteria for the diagnosis of probable 
RLS in children 
• The child meets all essential adult 
criteria for RLS, except criterion 4 
(occurrence only or worsening in the 
evening or night). 
Criteria for the diagnosis of possible 
RLS in children 
• The child is observed to have behavior 
manifestations of lower extremity 
discomfort when sitting or lying, 
accompanied by motor movement of 
the affected limbs.  The discomfort is 
characterized by RLS criteria 2-5 (is 
worse during rest and inactivity, 
relieved by movement, worse in the 
evening or night, and is not solely 
accounted for as primary to another 
medical or a behavioral condition). 
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B. Intermittent RLS: symptoms when not 
treated would occur on average 
<2/week for the past year, with at least 
five lifetime events.  
Specifiers for clinical significance of 
RLS: 
The symptoms cause significant distress 
or impairment in social, occupational, 
educational or other important areas of 
functioning by their impact on sleep, 
energy/vitality, daily activities, behavior, 
cognition, or mood. 
 
Table 2. International RLS Study Group (IRLSSG) Diagnostic Criteria for RLS.12,14 
RLS is underdiagnosed in both the adult and pediatric populations.  In children, it 
is estimated that the prevalence of RLS is between 2% to 4%.14 However, studies have 
shown that up to 44% of the ADHD pediatric population experiences RLS symptoms.15 
Several hypotheses have been proposed to explain this association between RLS and 
ADHD.  Biologically, both disorders have been tied to pathological deficits in the 
dopaminergic system of the brain.16 There is evidence for decreased dopaminergic 
function in the midbrain, frontal, and prefrontal regions of those children with ADHD, 
and in RLS there seems to be reduced dopamine synthesis.17,18 It is already well 
established that iron is a key in the dopamine system as it is needed to produce this 
neurotransmitter, maintain receptor function in the brain, and to synthesize myelin.9 Iron 
is the rate-limiting step in the conversion of tyrosine to levodopa, one of the important 
precursors to dopamine. When there is less iron available to make levodopa, the 
production of dopamine is decreased.19 Figure 1 illustrates this relationship. Because of 
this common underlying central nervous system pathophysiology, iron status has become 




Figure 1. Conversion of levodopa to dopamine.19 
Ambiguous data have been found in regard to iron status and ADHD.  Reduced 
brain iron has been hypothesized as an underlying cause of ADHD. Reduced peripheral 
iron stores—documented by serum ferritin, the most widely accepted and standardized 
gauge of iron deficiency—have been used most often to assess this relationship.20,21 
Many studies have examined serum ferritin levels in patients with ADHD for a possible 
peripheral iron deficiency, but the results have been mixed.17 The majority have found 
that peripheral serum levels are significantly lower in those with the disorder when 
compared to a control group.  Most have also found that serum ferritin is inversely 
correlated with ADHD symptom severity.22-32 However, there have also been studies that 
have failed to confirm such a relationship or to find significant differences between 
ADHD patients and healthy controls.33-36 Overall, differing eligibility criteria and 
methodology between studies measuring serum ferritin in the ADHD population seem to 
be the reasons for such variable results.17 
 Similarly, iron deficiency has been considered to be a significant contributing 
cause of RLS since the disorder was first described.37,38 Serum ferritin level has been 
shown to be related to RLS severity39, and, because of this, iron supplementation has 
been used as a therapy to help improve the unpleasant leg symptoms of children with 
RLS and concurrent iron deficiency.18,40-45 The high prevalence of RLS in the pediatric 
ADHD population, the mixed results regarding the relationship between ADHD and 
serum ferritin levels, and the strong relationship between RLS and iron deficiency 
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suggests that the subset of children with comorbid ADHD and RLS may be those most at 
risk for iron deficiency and worsening symptom severity.  
1.2 Statement of the Problem 
The subset of children with comorbid ADHD and RLS is an important population 
to study.  ADHD is the most commonly diagnosed childhood condition today, and there 
is ongoing debate, both scientifically and publicly, as to whether ADHD is overdiagnosed 
in children.  Stimulant use has steadily increased over the last 20 years, and as of 2012, 
about two-thirds of children diagnosed with ADHD were treated pharmacologically.46 
However, up to 75% of ADHD children meet the criteria for another psychiatric 
diagnosis.47 RLS produces symptoms that overlap with the criteria for ADHD, while at 
the same time disrupting sleep patterns and affecting daytime function in children.  There 
is currently limited information regarding the processes underlying their comorbidity and 
the factors associated with its risk.  Further investigation will prove valuable to help 
adequately treat the ADHD pediatric population.  
The association between serum ferritin levels and comorbid ADHD and RLS has 
not been thoroughly researched.  Four major studies have examined this subgroup of the 
pediatric population.  In 2003, Konofal et al. first reported a correlation between serum 
ferritin levels, ADHD index, and RLS symptom severity in ADHD children.  In 2007, 
this same group of researchers carried out the first study to date assessing iron levels in 
children with both ADHD and RLS, comparing them to children with ADHD and age- 
and sex-matched controls.10 The authors found that mean serum ferritin levels were 
lowest in the group of children with the comorbid condition, and that such levels were 
associated with high ADHD index scores. However, a small sample size was used, and 
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although there was a statistical difference with controls, there was no statistical difference 
from the group of children with ADHD alone. Oner et al. and Kapisyzi et al. examined 
this same subgroup of patients and also found that there was a higher prevalence of iron 
deficiency among this group as compared to a group of children with ADHD alone.48,49 
However, they found no association between iron deficiency and ADHD symptom 
severity.  
A question that all of this research provokes is why children with comorbid 
ADHD and RLS are more likely to have lower serum ferritin levels than healthy children 
or children with either disease alone. The most common cause of iron deficiency in 
children is an iron-poor diet.50 Diet has often been identified as a culprit for the 
development of ADHD, and there has been research examining this relationship.  
However, there has been only a limited amount of research characterizing dietary intake 
and serum nutrients.36 Over the past 12 years, 5 studies have measured dietary iron intake 
in ADHD children.33,35,36,51,52 The two most recent have shown lower iron intake among 
ADHD children than healthy controls.  Lifestyle factors, such as diet quality, have been 
proposed to have an effect on the risk or severity of RLS53, but the relationship between 
dietary iron intake in RLS patients has not been investigated thus far.  Therefore, our 
knowledge of dietary iron consumption with the comorbid condition of ADHD and RLS 
remains limited and incomplete.  Given that children with both disorders have shown to 
be the subset of the ADHD population with the lowest serum ferritin levels, further 
studies are needed to explore the effect that diet may be having on both their sleep and 
daytime functioning.  
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Furthermore, it is important to note that most patients with RLS who have low 
serum ferritin levels do not actually have anemia.18,54,55 Low serum ferritin status has 
been shown to contribute to the development of RLS symptoms.  Traditionally, oral iron 
supplementation has been recommended for serum ferritin levels of  <50 ng/ml, which is 
considered a low-normal value.  Practitioners generally target an optimal serum ferritin 
range of 50 to 100 ng/ml, which reflects a more adequate iron status.56 However, more 
recent studies have shown that iron supplementation should begin with serum ferritin 
levels below 75 ng/ml.57 Prior research suggests that children with ADHD and RLS are 
more prone to low iron stores.  If this is true, further investigation is needed to determine 
what guidelines to follow when addressing initiation of iron supplementation in this 
population.  
Lastly, as previously discussed, iron is a critical component of dopamine 
synthesis in the brain, and low brain iron stores can cause dopaminergic dysfunction. The 
majority of brain iron is found in ferritin as it is transported from serum to cerebrospinal 
fluid.55 It has been hypothesized that in RLS, low brain iron concentration is caused by 
the dysfunction of iron transport from serum to the central nervous system.  However, in 
those children with comorbid ADHD and RLS, no investigation into such a mechanism 
has been made.  If a low iron diet is associated with low serum ferritin levels, the 
underlying pathological process in these patients will prove to be multifactorial, not only 
attributable to the faulty brain iron transport hypothesis. 
1.3 Goals and Objectives 
 The primary goal of this study is to determine the role of diet in the pediatric 
development of comorbid ADHD and RLS. More specifically, we seek to identify and 
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analyze the association between mean dietary iron intake and serum ferritin levels in 
children ages 4-16 with comorbid ADHD and RLS and to compare this to the same 
associations in healthy children and children with either disorder alone. By completing 
this study, we hope to identify dietary iron consumption as a modifiable risk for children 
suffering from both diseases.  As a secondary goal, we aim to further confirm the 
prevalence of low serum ferritin levels in this specific population using a large-scale 
sample size.  Only four prior studies have examined serum ferritin levels in children with 
ADHD and RLS, and they all have used a relatively small sample.  Lastly, we plan to 
determine if dietary iron intake and serum ferritin levels are correlated with ADHD 
symptom severity.  
1.4 Hypothesis 
 Children between the ages of 4 and 16 with comorbid ADHD and RLS are more 
likely to have both a low dietary iron intake and low serum ferritin level as compared to 
healthy controls and children with either ADHD or RLS alone.  
1.5 Definitions 
• Low dietary iron intake will be defined from the collection of mean dietary iron 
intake, measured in mg/day, using a median split technique.  Those patients with a 
mean dietary iron intake less than the median of all sample values will be categorized 
with a low dietary iron intake. 
• High dietary iron intake will be defined from the collection of mean dietary iron 
intake, measured in mg/day, using a median split technique.  Those patients with a 
mean dietary iron intake greater than the median of all sample values will be 
categorized with a high dietary iron intake. 
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• Low serum ferritin level will be defined from the collection of serum ferritin levels, 
measured in ng/ml, using a median split technique.  Those patients with serum ferritin 
levels less than the median of all sample values will be categorized with a low serum 
ferritin level. 
• High serum ferritin level will be defined from the collection of serum ferritin levels, 
measured in ng/ml, using a median split technique.  Those patients with serum ferritin 
levels greater than the median of all sample values will be categorized with a high 
serum ferritin level. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
 A thorough and systematic review of the evidence regarding the association 
between serum ferritin levels, dietary iron intake, and RLS in individuals with ADHD 
was conducted using Ovid MEDLINE, PubMed, Scopus, Embase, PsychINFO, and Web 
of Science databases.  The following keywords were used in various combinations: 
ADHD, attention-deficit/hyperactivity disorder, attention deficit disorder, ADD, restless 
legs syndrome, RLS, iron deficiency, iron, serum ferritin, dietary iron, iron intake, and 
diet.  All relevant papers were reviewed from 1994, when the American Psychiatric 
Association published the Diagnostic and Statistical Manual of Mental Disorders, until 
April 2016 to obtain the most comprehensive and up-to-date information.  Because 
ADHD and RLS exist in both the pediatric and adult populations, papers examining both 
age groups were included.  Case-control, cross-sectional, cohort, and randomized 
controlled trial studies were included, in addition to systematic reviews. Searches were 
also performed on these same databases for relevant research on confounders and 
methodology.  
2.2 Review of Empirical Studies 
 There have been no studies addressing the relationship between dietary iron 
intake and serum ferritin levels in the population of children with comorbid ADHD and 
RLS. Thus, this section will review studies that have examined iron status in that specific 
population, as well as dietary iron intake in both populations separately.   
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Serum Ferritin Levels in Comorbid RLS and ADHD. The first study 
examining the relationship between serum ferritin and symptom severity in the subset of 
ADHD children with RLS was in Paris in 2003, when Konofal et al. assessed 43 children 
with ADHD for RLS according to the IRLSSG criteria. The mean age of children 
recruited was 9.2 ±2.2 years, and ADHD was diagnosed using the DSM-IV criteria.  
Eligibility criteria included being medication free for at least 2 months and no previous 
iron supplementation. Nineteen of the 43 children (44%) met the guidelines for “definite” 
or “probable” RLS.  The authors also measured serum ferritin levels and found that 
ADHD symptoms negatively correlated (p<0.0001).  Serum ferritin level was also 
negatively correlated with RLS severity in this population.  However, limitations to this 
study include the small sample size and the absence of any comparison group.1  
The first study to make such comparisons was a matched, cross-sectional study by 
Konofal et al. in 2007 of 22 children with ADHD and a group of 10 controls between the 
ages of 5 and 8.  Inclusion criterion for ADHD cases was a diagnosis of ADHD 
according to the DSM-IV criteria, and exclusion criteria included the presence of 
additional mild to moderate behavioral, mood, or anxiety disorders, physical diseases, 
and malnutrition.  Controls did not meet diagnostic criteria for ADHD, RLS, or any other 
psychiatric disorders. They were age- and sex-matched with cases.  None of the children 
involved were on medication for ADHD, RLS, or sleep at the time of assessment.  In 
addition, none were using supplemental iron. RLS was then diagnosed in the ADHD 
group based on the National Institutes of Health (NIH) consensus criteria for RLS in 
children.  They included children with definite, probable, and possible RLS.  ADHD 
symptom severity was measured using the Conners’ Parent Rating Scale (CPRS) and 
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scored on a four-point Likert-type scale. Twelve of the 22 ADHD cases had comorbid 
RLS, and analysis of variance (ANOVA) was used for between-group comparison of 
serum ferritin and symptom severity.  There was a statistical difference (p=0.001) 
between the comorbid group and controls for mean serum ferritin, but no statistical 
difference between the comorbid group and ADHD without RLS group.  However, 
children with a comorbid condition had the lowest mean ferritin levels, followed by those 
with ADHD only. Children with ADHD and RLS had a higher severity of ADHD 
symptoms compared with ADHD without RLS and non-ADHD children, but these 
differences were not significant. Although the study design limits any implication of 
causality, results would have been stronger and more reliable if the study had been 
properly powered.  Differences between groups were present, yet insignificant given the 
small sample size. Furthermore, these results are not generalizable to the entire pediatric 
population, as no participant was over the age of 8 years.2  
 In a cross-sectional study later that year, Oner et al. sampled 87 ADHD subjects 
from a general outpatient hospital clinic that were diagnosed with the disorder. Unlike the 
previous study, the age range of these participants was 6-16 years.  Children were 
included if they had an ADHD diagnosis. Exclusion criteria included the presence of 
primary or secondary sleep disorders, epilepsy, peripheral neuropathy, radiculopathy, 
psychosis, mental retardation, and any acute medical condition that might lead to 
alterations in serum ferritin and iron levels. Oner’s group measured the frequency of RLS 
in these children using the IRLSSG criteria for definite RLS. They then compared ADHD 
symptom severity and iron deficiency, defined as a serum ferritin level <12ng/ml, 
between those children with the comorbid disorders and those with ADHD alone. Using a 
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Fisher’s Exact Test, there were significantly higher rates of iron deficiency in ADHD 
subjects with RLS than those without (p=0.005).  There was no statistical difference in 
ADHD symptom severity, measured using the Child Behavior Checklist, Teacher Report 
Form, the Conners’ Parent Rating Scale, and the Conners’ Teacher Rating Form, between 
the two groups.  The results of this study are important because they fall in line with 
those of Konofal et al. in terms of serum ferritin.  However, their definition of iron 
deficiency as <12 ng/ml is somewhat problematic given that the current, accepted value 
used for initiation of iron supplementation is <50 ng/ml. Only 6 of the 29 children with 
the condition were found to have iron deficiency as compared to 1 of the 58 with ADHD 
alone.  Such a narrow definition neglects those children who may be experiencing 
increased ADHD and RLS symptom severity with low serum ferritin levels, although 
they may not technically fit the stated definition for iron deficiency.3  
 Kapisyzi et al. performed a cross-sectional study similar to Oner’s in 2010 using 
43 ADHD subjects, with average age of 16.3 ± 2.5 years, diagnosed by a psychiatrist 
using the DSM-IV criteria.  These children were further evaluated for RLS using the 
IRLSSG criteria.  RLS was found in 32.5% of the subjects, however the severity of 
ADHD symptoms was not statistically significant between those with and without RLS (p 
> 0.05).  These authors also defined iron deficiency as serum ferritin <12 ng/ml, and the 
rate of iron deficiency was statistically higher in ADHD subjects with RLS when 
compared to ADHD subjects without RLS (p=0.005).  This study showed that iron 
deficiency increases the risk of having RLS in ADHD children. However, the results are 
not generalizable to the entire pediatric population, as only adolescents between the ages 
of 13 and 18 were sampled.4   
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 All four of the above studies fail to recognize diet’s influence on serum ferritin 
levels. They all suggest that low serum ferritin or iron deficiency increases the risk of 
having RLS in ADHD children, but offer no information as to why such a deficiency 
occurs.  Furthermore, both Oner et al. and Kapisyzi et al. reported a disproportionate 
female/male ratio (1 to 9) that may have clouded the results, and they failed to use a 
healthy control group for comparison.  Konofal et al., however, used gender- and age-
matched controls in order to take such variables into account in their study design, but did 
so using only a narrow age range of subjects (5-8 years).  
Dietary Iron Intake, RLS, and ADHD.  Dietary iron intake has not been 
specifically explored in either adult or pediatric comorbid ADHD and RLS populations. 
There have been studies looking at dietary iron intake in the ADHD population, and one 
recent study investigating diet quality in adult RLS patients.    
 In 2004, Chen et al. conducted a cross-sectional study on the relationships 
between ADHD and nutritional factors in children in Taiwan.  Fifty-eight children 
diagnosed with ADHD using the DSM-IV criteria and 52 control subjects, between the 
ages of 4-12, were recruited from local schools to complete a 3-day diet record. 
Participants were allowed to pick 3 continuous days in which to record their meals.  From 
there, a computer software program was used to analyze the diaries for food components.  
In addition to the food record, patients provided a fasting blood sample that was used to 
measure different biochemical data; among them was iron.  The authors found 
statistically significant differences in both iron intake and blood iron content between the 
ADHD and control groups (p < 0.05).  The ADHD subjects consumed 43% more iron 
and had a higher iron content in the blood.  The authors concluded that based on these 
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results, diet failed to explain the relationship between iron deficiency and ADHD. 
However, this study was subject to study bias due to the fact that children with the 
disorder were volunteers from the hospital and were not representative of the general 
population.  Also, patients were allowed to choose the days of the week in which they 
filled out their food diary, not taking into account the variability that this difference could 
cause.  Lastly, this study failed to take socioeconomic status, which could potentially 
influence both diet and ADHD, into account.5  
 In 2009, Menegassi et al. performed a controlled cross-sectional study that 
hypothesized that children with ADHD on methylphenidate would have lower iron levels 
than those patients not on the stimulant due to decreased appetite caused by the 
medication.  Sixty-two children and adolescents between the ages of 6-15 were divided 
into three groups: patients with ADHD in exclusive and uninterrupted use of immediate-
release methylphenidate, patients with ADHD without medication use, and a healthy 
control group from a primary care center. Children with ADHD were from an ADHD 
Outpatient Clinic. Nutritional assessment was made with a 24-hour dietary recall, a 
dietary record over 4 days (two weekdays and a full weekend), and a food-frequency 
questionnaire. Heme-iron was measured in red and dark meats in mg/day.   Additionally, 
both blood draws and parasitological feces exams were performed on each participant. 
Serum ferritin was measured in ng/ml and abnormal results were indicated with the 
following three cut-off scores: ≤15 ng/ml, ≤30 ng/ml, and ≤45 ng/ml.  The authors found 
no significant differences in the values of heme-iron among the groups using the 24-hour 
recall (p=0.62), dietary record (p=0.62), or food-frequency questionnaire (p=0.81).  
Likewise, no statistical differences were found in serum ferritin levels for the cut-off 
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scores of 30 ng/ml (p=0.44) and 45 ng/ml (p=0.96).  The study suggests that serum 
ferritin levels and iron intake do not differ between children with ADHD (on or off 
medication) and healthy controls.  Furthermore, it suggests that stimulant medication is 
not associated with decreased dietary intake. A major strength of this study was the 
stringent eligibility criteria imposed on participants, which helped to restrict confounding.  
Exclusion criteria included: an IQ below 70, the coexistence of other psychiatric 
disorders with exception of conduct disorder and oppositional defiant disorder, and the 
presence of any factor that could interfere with serum iron level including supplemental 
iron use in the past 3 months, parasitosis, acute or chronic infections, inflammatory 
processes, blood loss, and chronic diarrhea.  However, children with ADHD were 
selected from outpatient clinics.  If this was not done systematically, then there may be 
some selection bias making the results imprecise.  Furthermore, the authors stated that 
they needed 225 participants in each group in order for the study to be sufficiently 
powered and to detect a 5% significance level. This further explains their outcomes.6   
 Kiddie et al. (2010) reported findings similar to Menegassi et al. in a case-control 
study assessing dietary food intake and nutrient status of DSM-IV diagnosed ADHD 
children ages 6-12 sequentially recruited from an ADHD Program. Unlike Menegassi’s 
study, all participants were on medication for ADHD and there was no control group.  All 
participants had to have been stable on their current medication for at least 6 months and 
had to be taking it 7 days a week.  Participants were excluded if they were on additional 
medications that altered food intake or had any other medical conditions that could alter 
nutritional status.  Serum ferritin was measured from a nonfasting blood sample, and 
mean dietary iron intake (mg/day) was calculated from a 24-hour food recall and a 3-day 
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food record (from two weekdays and one weekend day).  Iron intake was then compared 
to the Estimated Average Requirement (EAR) and U.S. dietary intake data from the 
second National Health and Nutrition Examination Survey (NHANES II).  No significant 
differences in iron intake (95% CI -4.8052 to 11.0135) or serum ferritin (p=0.582 with 
95% CI: -7.2207 to 12.5294 and p=0.786 with 95% CI: -7.9672 to 10.3422 for ages 6-8 
and 9-11, respectively) were found, and all participants met the Estimated Average 
Requirement for iron intake.  The results suggest that serum ferritin levels and iron intake 
do not differ between children with ADHD and national norms.  However, a major 
weakness of this study is that it did not control for iron supplementation. This 
confounding variable may be masking a real difference in both of these measures.  
Furthermore, only 44 subjects were examined.  
 In contrast, two recent studies showed lower iron intake among children with 
ADHD. Durá Travé et al. used a case-control methodology evaluating the dietary patterns 
in a group of 100 children with ADHD being treated with methylphenidate extended 
release medication and 150 healthy controls without ADHD.  ADHD children were 
diagnosed using the DSM-IV criteria and had to be on extended release methylphenidate 
for at least 12 months.  They were grouped into two subtypes: those with predominantly 
inattention and those with primarily hyperactivity and impulsivity.  Exclusion criteria for 
both groups included any chronic condition known to affect nutritional status, use of 
vitamin or mineral supplements, or those who had stopped taking medication during 
summer breaks.  Each participant filled out a 3-day food diary, and macronutrient, 
mineral, and vitamin intake were calculated using a nutritional database.  Among other 
vitamins and minerals, the control group showed significantly higher iron ingestion in mg 
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(p<0.05) compared to the groups with ADHD.  Furthermore, all of the children in the 
control group surpassed the recommended intake for iron in contrast to the groups with 
ADHD (p<0.05). A major drawback of this study was that any confounding factors, such 
as socioeconomic status and education level, were overlooked by the researchers.8 
 In 2015 Energin et al. published a case-control study comparing the nutritional 
status and anthropometric characteristics of children between the ages of 8-11 with and 
without ADHD.  100 children with ADHD from a child and adolescent psychiatry 
department in Turkey voluntarily enrolled in the study, while a healthy control group of 
100 children was recruited from a school in a part of the city that had similar 
socioeconomic status with the ADHD group (p>0.05).  Inclusion criteria included a 
DSM-IV diagnosis of ADHD.  Exclusion criteria included mental retardation and 
neurologic or chronic illness.  Children in the control group were excluded if they had 
current or past psychiatric illness or any chronic disease. Like the previous studies 
discussed, a 3-day food record was given to each patient after parents were trained by a 
dietician to record dietary intake.  Patients were instructed to record a period of three 
consecutive days (two weekdays and one weekend day).  A photographic atlas of portion 
sizes was used to evaluate portions and amounts.  A nutrition information system was 
used to calculate both the energy and nutrients from the records, and, using the Dietary 
Guidelines for Turkey, deficiencies were defined as intakes less than 67% of the 
guidelines.  Statistical analysis was stratified by gender. Intake levels of all nutrients 
examined (including iron) were significantly lower in boys with ADHD than in healthy 
boys (p<0.05).  Girls with ADHD showed lower intake levels of all nutrients except for 
vitamin A and thiamine.  However, the difference in iron intake was not statistically 
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significant (p=0.14).  Furthermore, all anthropometric measurements of children (weight, 
height, BMI, waist circumference, hip circumference, mid-upper arm circumference, and 
hand grip strength) were lower in the children with ADHD (both boys and girls). 
However, there were only statistical differences between handgrip strength in boys 
(p<0.05) and waist circumference and handgrip strength in girls (p=0.04 and p=0.01, 
respectively). This study was important in that it found an association between lower 
energy and nutrient intake in children with ADHD, and it suggested that their physical 
condition might be a reflection of this.  However, although the authors tried to account 
for socioeconomic influence on the results, they did not take any other potential 
confounders into account, particularly medication use.9  
 In terms of RLS, a prospective cohort study published by Batool-Anwar et al. just 
this year examined the association between modifiable lifestyle factors and the risk of 
developing RLS in 167,959 adults participating in the Health Professionals’ Follow-up 
Study and the Nurses’ Health Study II over 4-6 years of follow-up.  RLS was diagnosed 
based on the IRLSSG criteria, and among other lifestyle factors ascertained, the authors 
assessed diet quality by the Alternate Healthy Eating Index (AHEI).  The conformance to 
the Dietary Guidelines for Americans for vegetables, fruits, nuts, soy, cereal fiber, white-
red meat ratio, polyunsaturated: saturated fat ratio, trans-fat, and multivitamin use was 
assessed, and participants were given a rating from 0-10 based on their eating behavior.  
A score of 10 was considered healthy dietary behavior. The authors found no significant 
association between RLS and diet quality.  However, when performing lagged analyses, 
there was an association between diet and RLS that suggested perhaps patients with the 
disorder changed their eating habits before they developed symptoms. This study’s 
 25 
strengths included a large sample size and small chance of recall bias given its 
prospective design.  However, iron supplementation was used as a surrogate measure for 
iron deficiency, which has the potential to cause residual confounding.10   
2.3 Review of Studies Identifying Possible Confounding Variables 
 Several studies have investigated the factors that influence dietary intake and 
absorption of iron by the body, in patients with ADHD and RLS.  The findings of these 
studies will be discussed in order to identify potential confounders that will be accounted 
for in the proposed study.  
Socioeconomic Status. Socioeconomic factors—such as race, education, income, 
and occupation—have been a topic of interest regarding diet and micronutrient intake for 
many years.11-18 It has been found that those groups of people with lower incomes and 
education levels have higher rates of obesity, more diet-related disease, and poor diets.14 
In 2008, Kranz et al. examined sociodemographic, dietary, and anthropometric data from 
1,521 children between the ages of 2-5 who participated in the National Health and 
Examination Survey 1999-2002.18 The authors found that diet quality decreased with 
increasing age (p<0.001) and improved with increasing family income (p<0.001). Race 
also played a role, as Hispanic children’s diet quality index scores were significantly 
better than those of non-Hispanic white children (p=0.033). In another cross-sectional 
study assessing dietary intake and socioeconomic status, Hulshof et al. analyzed 2-day 
food diaries from 12,965 adult participants and found that a higher socioeconomic status 
was associated with a higher intake of micronutrients, including iron (p<0.01).11  
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Socioeconomic status has also been known to influence serum ferritin levels.19,20 
Iron deficiency has been documented to be more common among groups of low 
socioeconomic status.21 Gompakis et al. conducted a cross-sectional study exploring the 
relationship between dietary habits, socioeconomic status, and iron deficiency in children 
between the ages of 8 months to 15 years.20 These authors found a higher incidence of 
iron deficiency (hemoglobin ≥11 g/dl and ferritin <10 ng/ml) and iron deficiency anemia 
(hemoglobin <11 g/dl and ferritin <10 ng/ml) in children at any age in semiurban areas 
that had more citizens of lower socioeconomic status as compared to urban areas 
(p<0.001).  Similarly, Kim et al. performed a cross-sectional study in Korea examining 
the relationship between household income and the prevalence of iron deficiency, 
anemia, and iron deficiency anemia.19 The authors found as income level decreased, the 
risk for anemia or iron deficiency anemia increased.  When compared to the high-income 
group, the odds ratio for anemia was highest in the lowest income group (OR 7.10, 95% 
CI 2.49, 20.23).  
Socioeconomic status has also been shown to be a risk factor in the development 
of both ADHD and RLS.   In 2014, Russell et al. performed a mediation analysis of data 
from 8,132 children in a longitudinal cohort study, focusing on socioeconomic factors 
and the diagnosis of ADHD.22 The authors measured socioeconomic status using 8 
indexes and found that the strongest predictor of ADHD was financial difficulty (OR 
2.06, 95% CI 1.44-2.94, p<0.001).  Socioeconomic status has also been explored in RLS. 
Two prospective population-based cohort studies, the Dortmund Health Study and the 
Study of Health in Pomerania, assessed RLS twice in 5,620 adults according to the 
IRLSSG criteria and measured sociodemographic factors through interviews.23 The 
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authors found that low educational achievement and low income level were significant 
risk factors for RLS in one study (OR 2.29, 95% CI 1.14-4.59, p=0.02 and OR 1.63, 95% 
CI 1.05-2.52, p=0.03, respectively) and that unemployment increased the risk for RLS in 
both (OR 3.10, 95% CI 1.30-7.42, p=0.01 and OR 1.61, 95% CI 1.03-2.53, p=0.04).   
Iron Supplementation. Studies analyzing dietary iron intake or serum ferritin 
levels have typically excluded patients on the basis of iron supplementation because 
supplemental iron may mask the relationship between dietary behavior and serum ferritin 
level.  Children who use supplemental iron may not be getting adequate iron in their 
diets, or they may alter the foods they eat knowing that they can receive iron through 
supplements.  Supplemental iron will produce normal peripheral serum ferritin levels, 
even if diet is inadequate. Both Menegassi et al. and Durá Travé et al. excluded those 
patients who had used iron supplementation.6,8 Kiddie et al. did not control for nutrient 
supplementation, making it hard to determine the effects of dietary intake on those 
variables involved in ADHD.7 
There have been several studies demonstrating the efficacy of iron 
supplementation for reduction of both ADHD and RLS symptom severity.  In a double-
blind, placebo-controlled, randomized trial, Konofal et al. looked at the effect of 12 
weeks of ferrous sulfate tablet therapy after randomization of 23 iron deficient (serum 
ferritin <30 ng/mL) nonanemic children with ADHD.24 Measuring ADHD symptoms 
using the ADHD Rating Scale after 12 weeks, the authors found that there was a 
statistically significant decrease (p<0.008) in severity in the treatment group but not in 
the placebo group (p=0.308).  Iron supplementation has been even more researched and 
supported in patients with RLS.25-34 In 2009, Wang et al. performed the first double-
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blind, placebo-controlled study looking at oral iron supplementation in symptomatic 
patients with RLS and low-normal serum ferritin levels (15-75 ng/ml).25 Eleven adults 
received 12 weeks of ferrous sulfate and the authors found that there was a statistically 
significant decrease in their RLS symptom severity as compared to the placebo group 
(p=0.01).   
Stimulant Use. Stimulants are the treatment of choice for ADHD patients. 
However one of their side effects includes decreased appetite.35,36 Low dietary iron intake 
could therefore be due to a reduction in intake of iron-rich foods of those children who 
are being medicated with stimulants.  Related to this, Calarge et al. performed a cross-
sectional study in which they measured serum ferritin levels of 52 children with ADHD 
undergoing a trial of amphetamine medication.37 The authors found children with lower 
serum ferritin concentrations required higher doses of medication (p=0.03), concluding 
that stimulant medication is related to serum ferritin levels.  A recent study done by 
Percinel et al. found that when observing a group of stimulant-naïve children with 
ADHD, iron deficiency parameters, symptom severity, and serum ferritin levels were not 
significantly different between different ADHD presentation types.38 This suggested that 
psychostimulants may play a role in the previously documented relationships between 
these factors. They also cited lack of information regarding nutrition and dietary intake as 
a limiting factor in their study. 
 Age and Gender. Age and gender are also other potential confounders to the 
proposed study.  It is well known that the growth spurt in adolescence affects iron 
metabolism and iron requirements.39 The increase in mean total iron requirements in 
teenage boys more than doubles the requirements of preadolescent males due to the 
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expansion of the total blood volume and the increase in lean body mass.40 In addition to 
these same growth requirements, adolescent females begin to lose iron after the initiation 
of their menstrual cycles.41 To balance these losses, daily iron requirements nearly double 
for teenage girls as compared to preadolescent females.40 Because of their rapid growth, 
menstrual blood losses, and poor dietary intake, adolescent females are the most 
susceptible to dietary iron deficiency.42 Furthermore, as children age, they begin to show 
more undesirable eating behaviors, such as skipping breakfast and family dinners.43 
These tendencies are associated with decreased diet quality and failure to meet dietary 
recommendations.44 A longitudinal study by Mannino et al. tracked dietary intake of girls 
at ages 5, 7, and 9, and they found a statistically significant decrease in the nutrient 
density of iron in the diets from age 5 to 9 (p<0.0001).45 
 Age and gender are also risk factors in the development of ADHD and RLS. In a 
longitudinal cross-sectional study performed by Döpfner in 2015, the ADHD symptoms 
of inattention, hyperactivity-impulsivity, and both combined were measured in children 
and adolescents between the ages of 7-19.46 The authors then separated patients into 
subgroups (high, moderate, and low) according to different developmental trajectories 
and found a decrease in symptoms with age in almost all severity groups (p<0.01). 
Furthermore, researchers from the Centers for Disease Control and Prevention have 
found that boys (13.2%) are more likely than girls (5.6%) to have ever been diagnosed 
with ADHD.47 Energin et al.’s study previously discussed also showed that differences 
exist between boys and girls with ADHD and their dietary patterns.9  
Age and gender have also been known to be risk factors for RLS.  The separate 
diagnostic criteria first established by the IRLSSG in 2003 for children under the age of 
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12 recognized the fact that RLS diagnosis is difficult in the younger populations.48 Berger 
et al. performed a study in 2004 and found that the prevalence of RLS increased with age 
in both males and females.49 They also found that women were twice as often affected 
with RLS than men (OR 2.64, 95% CI 1.92-3.39, p<0.001).  This is consistent with other 
research citing evidence for a female preponderance in the prevalence of RLS.50,51 
BMI. Elevated BMI has been associated with low serum ferritin levels, as well as 
the development of ADHD and RLS.  In a study performed by Pinhas-Hamiel et al. in 
2003, the authors measured BMI and mean iron level in 321 children and adolescents.52 
They found that iron levels below 8 μmol/l were noted in 38.8% of obese patients 
(BMI>97th percentile), 12.1% of overweight patients (85th percentile <BMI<97th 
percentile), and only 4.4% of the normal-weight patients (BMI<85th percentile) with 
p<0.001. Research regarding the association between BMI and ADHD has been 
increasing recently, and multiple studies have shown that they could be related.53-55 A 
prospective cohort study done by Anderson et al. found that children with ADHD, female 
or male, had higher BMI z scores at all ages compared with subjects without a disruptive 
disorder.  Likewise, in Batool-Anwar et al.’s prospective cohort study assessing risk 
factors for RLS, obesity was associated with an increased risk of having RLS, with the 
odds ratio for women with a BMI >30 kg/m2 (categorized as obese) versus <25 kg/m2 
was 1.64 (95% CI 1.37-1.96, p<0.0001).  The corresponding odds ratio for men was 1.46 
(95% CI 0.96-2.2, p<0.005).   
Malabsorption. Intestinal malabsorption of micronutrients has been cited to be a 
cause of low serum ferritin levels in RLS patients.56,57 Celiac disease, a chronic immune-
mediated disorder in which villi of the small intestine are destroyed and unable to 
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properly absorb nutrients, has been associated with RLS.  In a consecutive case series 
done by Manchanda et al., the authors found four patients with RLS and serum ferritin 
below 25 ng/ml who had a positive serological screening for celiac disease.56   
Infection. Lastly, infection and inflammation have the potential to raise serum 
ferritin levels.58-60 In a longitudinal study done by Birgegård et al., serum ferritin samples 
of 18 patients hospitalized for acute infections, both bacterial and viral, were taken during 
their time in the hospital and afterwards at follow-up.59 The authors found that serum 
ferritin rose within a couple days of onset of infectious symptoms and remained elevated 
past the acute phase and recovery. The difference in mean ferritin level during days 1-3 
after the onset of symptoms and the level after 35 days was statistically significant 
(p<0.05).   
2.4 Review of Relevant Methodology  
Study Design. The proposed study will be a matched, case-control study 
exploring the association between dietary iron intake and serum ferritin levels in children 
with ADHD, with and without comorbid RLS. As previously discussed, there are a 
number of confounding variables that have the potential to distort our comparisons. Age, 
gender, and socioeconomic status are such variables that have been shown to have strong 
influences on serum ferritin, dietary iron intake, and ADHD and RLS development. 
Konofal et al. matched for age and sex, and Energin et al. accounted for socioeconomic 
status.2,9 The proposed study will follow both methods. Socioeconomic status will be 
based on the income-to-poverty ratio, the ratio of household income and the poverty line 
published by the Census Bureau for a certain family size in that calendar year.61 Kranz et 
al. and Wang et al. both used this method in their study assessing diet quality and 
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socioeconomic status in data from the National Health and Nutrition Examination 
Surveys.18,61 A low socioeconomic status will be defined as an income-to-poverty ratio 
less than 1, and a high socioeconomic status will be defined as an income-to-poverty ratio 
greater than 3. A middle socioeconomic status will be any values between those just 
mentioned.  Individual matching on these three variables will allow the proposed study to 
start with subjects that have similar characteristics and to gain precision in the estimate of 
the effects.   
Patient Recruitment and Selection. Because the proposed study will be case-
controlled and will select for patients with ADHD, the recruitment process must be 
designed in an unbiased manner.  Kiddie et al. performed a case-control study to measure 
dietary iron intake, and the subjects were recruited in a sequential manner.7 The proposed 
study will use this technique as well.   
Furthermore, as discussed in Chapter 1, the DSM-5 and IRLSSG criteria are 
currently the most rigorous criteria used to diagnose ADHD and RLS, respectively. All 
studies previously cited have used the DSM criteria, and the proposed study will also use 
it. The Kiddie-SADS-Lifetime Version (K-SADS-PL) is a semi-structured interview that 
has been validated to assess current and past psychiatric history in children according to 
the DSM-IV criteria, and it will be used by clinicians in the proposed study.62 Currently, 
there is no validated, widely accepted RLS screening questionnaires for children, and so 
the proposed study will use versions developed by Mindell and Owens.63 Inclusion 
criteria have been consistent throughout the reviewed studies, however exclusion criteria 
have varied in each study.  Potential confounders have been identified, and, through 
matching, will be somewhat controlled for.  However, exclusion criteria will be used to 
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further remove any bias from the study. Exclusion criteria will include: major comorbid 
medical problems, iron supplementation, RLS therapy, current or recent infection, 
children under the age of 4 or over the age of 16, and children under the age of 9 whose 
parents cannot read or write English.  
Because we are interested in two specific disorders, we want to recruit relatively 
healthy children with ADHD only. Any children with major medical problems, other 
developmental disorders, cognitive impairment, eating disorders, or substance use 
disorders will be excluded from the proposed study. Each of these exclusion criteria were 
used in the previously described studies, and each has the ability to distort the association 
between dietary iron intake, serum ferritin levels, and ADHD.2,3,6,8,9 Iron supplementation 
was part of the exclusion criteria used in Menegassi and Durá Travé et al.’s studies, and 
Kiddie et al. failed to account for its use in their study.6-8 As previously mentioned, iron 
supplementation can cause discrepancies in dietary iron intake measurements, and 
influence serum ferritin level and the development of RLS and ADHD. Birgegård et al. 
found that infection can cause an increase in serum ferritin levels for up to a month after 
the infection is cleared, and so those children who have a current or recent infection will 
be restricted from the proposed study.59 Furthermore, RLS therapy will be part of the 
exclusion criteria.  The proposed study is interested in ADHD children with undiagnosed 
RLS. Children receiving RLS therapy will already be diagnosed. 
Lastly, the age group of interest is children between 4-16 years of age.  According 
to the American Academy of Pediatrics’ Clinical Practice Guideline for the Diagnosis, 
Evaluation, and Treatment of ADHD in Children and Adolescents, the diagnosis for 
ADHD can be made at the age of 4.64 Egger et al. performed a study in 2006 measuring 
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ADHD symptoms in preschool children, and found that the majority of ADHD symptoms 
occurred in less than 10% of the children assessed. The most common symptom, 
interruption/intrusion, was endorsed by 44.7% of parents of children without ADHD, 
while 100% of parents of children with ADHD endorsed the symptom (p<0.001).65   
3-Day Food Diary. Dietary iron intake will be measured using a 3-day food 
diary, with recording done on two weekdays and one weekend day.  All previous research 
measuring iron intake in the ADHD population that have been discussed thus far has used 
some kind of food diary to record iron intake. More specifically, Chen, Kiddie, Durá 
Travé, and Energin et al. all employed a 3-day food diary as the duration for 
measurement.7-9,66 The 3-day food record has been validated for use in children. 
Crawford et al. compared it to both a 24-hour recall, done through interview, and a 5-day 
food frequency questionnaire in girls between the ages of 9-10.  For the 3-day food 
record, children were educated on its use and portion sizes. Observers were assigned to 
watch each child at lunch, and the reporting of their meals was compared to what was 
seen by observers. The 3-day food record had the highest food agreement score (65% 
agreement) out of all methods.67 In the proposed study, one weekend day will be included 
for meal measurement to get an appropriate balance between days that are likely to differ 
with respect to food intake.  Furthermore, Singer et al. used 3-day food diaries to record 
nutrient intake in children between the ages of 3-8.68 By the age of 8, children were able 
to fill out their own food diaries.  Given these data, the proposed study will exclude any 
children under the age of 8 whose parents cannot read or write in English in order to 
prepare a food diary for them. 
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 Dietary iron intake will be assessed by trained dieticians using the Nutrition Data 
System for Research (NDSR) program. The NDSR was developed by the Nutrition 
Coordinating Center at the University of Minnesota and has an extensive food list that 
allows products to be added to the database.69-71 The program imputes nutrient content 
from labels so that total nutrient intake is not underestimated. Hyman et al. used this 
software to measure nutrient intake data from 3-day food records, and it has been 
licensed to the Yale University School of Medicine.70 
ADHD Symptom Severity. The Conners’ Parent Rating Scale (CPRS) will be 
used to assess ADHD symptom severity. The Conners’ scale is a widely used and 
validated instrument for screening and assessing behavior problems.72 The most updated, 
computerized version has strong DSM-5 connections.73 Both Konofal and Oner et al. 
used this scale when measuring symptom severity in their sample of children with 
comorbid ADHD and RLS.2,3 This form contains 48 items, which evaluate behavior of 
children assessed by their parents.74 It includes oppositional behavior, inattentiveness, 
hyperactivity, psychosomatic, and irritability domains.3,75 The form uses a four-point 
Likert scale, and a total score is generated.  
2.5 Conclusion 
 Several studies have shown statistically significant differences in serum ferritin 
levels among children with comorbid ADHD and RLS and controls.2-4 However, no 
studies have compared these children’s dietary iron intake to their serum ferritin levels. 
Although the literature examining dietary iron intake’s relationship with ADHD suggests 
that an association exists between the two variables in the population of children with 
both disorders, there is a gap in knowledge that warrants investigation.  It can be 
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concluded from the literature that a case-control study exploring this relationship while 
accounting for the potential confounders of age, gender, and socioeconomic status would 
be beneficial in advancing our knowledge of these two very common pediatric disorders.  
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CHAPTER 3: STUDY METHODS 
3.1 Study Design 
  We propose a matched case-control study to evaluate dietary iron intake among 
cases of children with ADHD and controls with no ADHD diagnosis, with or without 
comorbid RLS.  Cases and controls will be matched by age, gender, and socioeconomic 
status. To determine if there is an association between dietary iron intake and serum 
ferritin levels in children with comorbid ADHD and RLS, we will identify those children 
in both the case and control groups who have RLS based on the “definite” or “probable” 
IRLSSG criteria.  
3.2 Study Population and Sampling 
The study population will be drawn from patients at the Yale Child Study Center 
Outpatient Psychiatric Clinic for Children and the University of Connecticut Child and 
Adolescent Psychiatric Outpatient Clinic. Consecutive patients with a diagnosis of 
ADHD will be recruited from children coming in for initial or follow-up assessment at 
these clinics from August 2016 to June 2018.  Yale-New Haven Hospital and the 
University of Connecticut Health Center serve the same local populations in the state of 
Connecticut. Personal communication with staff at these sites indicated that close to 600 
children with a diagnosis of ADHD receive care from providers at these two outpatient 
clinics.  Their patient populations range from 60-67% Caucasian, 11-20% African 
American, and 20% Hispanic. The majority of patients are in the lower middle class or 
receive Medicaid. The large population of children with ADHD seen between these two 
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clinics, along with their very similar socioeconomic makeup, will help facilitate the 
matching process with controls.  
Prior to enrollment, consecutive clinic patients with a diagnosis of ADHD will be 
screened on specific inclusion and exclusion criteria.  Patients who meet eligibility will 
be included as participants in the study. Eligible ADHD subjects will be children aged 4-
16 and will have a history of ADHD.  A consultant child psychiatrist will confirm this 
diagnosis using the DSM-5 criteria by means of a semi-structured psychiatric interview 
that uses the validated Schedule for Affective Disorders and Schizophrenia for School 
Age Children-Present and Lifetime Version (K-SADS-PL).  Children with significant 
health problems other than ADHD, including pervasive developmental disorders, 
cognitive impairment, eating disorders, or substance use disorders will be excluded. 
Other exclusion criteria are: use of iron supplementation, current RLS therapy, current or 
recent infection (within 1 month), or being under the age of 8 with parents or guardians 
who cannot read or write English.  
The non-ADHD controls will be selected sequentially from the same clinics as the 
ADHD cases. They will be given the same full diagnostic assessment as those children 
with ADHD and will be screened for the absence of ADHD.  They will be subject to the 
same exclusion criteria as the cases. Figure 1 illustrates the eligibility criteria and patient 
selection process.  Because we are using a matched design, each case and control set will 
be the same age (difference between birthdays within 6 months), same gender, and 
similar level of socioeconomic status. Socioeconomic status will be assessed using the 
income-to-poverty ratio.  
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Figure 2. Flow diagram of patient selection. 
3.3 Subject Protection and Confidentiality 
 Before we begin recruiting participants for our study, we will first obtain approval 
from the Yale University Institutional Review Board, the Human Investigation 
Committee (HIC), as part of their Human Research Protection Program (HRPP) protocol.  
Because our subjects are children, the first draft of the proposal will be submitted to an 
oversight committee, the Pediatric Protocol Review Committee (PPRC).  They will 
review the proposal, application, and consent documents prior to submission to the HIC. 
This process will begin eight weeks prior to our anticipated start date of August 2016. All 
research personnel will complete the required Human Subjects Protection Training and 
Health Insurance Portability and Accountability Act (HIPAA) training prior to 
submission of our proposal to the review committee. They will also sign confidentiality 
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forms. Furthermore, because we will be working with clinicians, staff, and patients at the 
University of Connecticut Health Center, approval from their Institutional Review Board 
will be obtained as well. The Principal Investigator will submit this to the HIC.  
 We will provide an informed consent form to the parents or guardians of the 
children, along with a child assent form for patients under the age of 13 or an adolescent 
assent form for patients between the ages of 13-17. These can be found in Appendices A, 
B, and C.  Each of these documents will outline a description of the study, procedures, 
risks and inconveniences, benefits, confidentiality under the HIPAA privacy regulations, 
and the voluntary nature of the study.  This information will also be verbalized to the 
patient and his/her parents or guardians.  Eligible patients, their guardians, and the 
Principal Investigator must sign these documents before enrollment in the study. 
 All information collected during the study will be de-identified following HRPP 
policy.  Each participant will receive a study number that will be connected to their study 
data.  Any paper documents will be catalogued by subject number and will be locked in a 
file system.  Electronic information and records will be entered into password-protected 
computers that are on secure servers.  Only the Principal Investigators, research 
assistants, and involved medical professionals will have access to the locked file system 
and computers.  All participants will be given the research team’s contact information, 
and will receive copies of the consent and assent forms.  They will be informed that they 
have the opportunity to leave the study at any time they wish.    
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3.4 Recruitment 
All psychiatrists, physician assistants, and nurse practitioners involved in patient 
care at the Yale Child Study Center Outpatient Psychiatric Clinic and the University of 
Connecticut Child and Adolescent Psychiatric Outpatient Clinic will be informed about 
the study and its eligibility criteria.  As noted above, they will approach consecutive 
patients about participation in our research study.  If the patient agrees to a referral, the 
clinician will note this in the patient’s chart and send their information to us to initiate 
participation. We will contact the patient’s parents or guardians in order to set up a 
screening appointment.  During this visit, we will obtain consent from parents and assent 
from children so that the patients do not feel pressured by their healthcare provider to join 
the study.  The consent process will follow the order of referrals sequentially until the 
desired number of participants is achieved.    
3.5 Study Variables and Measures 
 Given that we will be implementing a case-control study, we will begin with cases 
of the disease.  In our study, the outcome variable we will select for, as explained above, 
is ADHD diagnosed using the DSM-5 criteria.  The primary predictor variable of interest 
is mean daily iron intake (measured in mg/day) recorded by patients and/or parents using 
a 3-day food diary. All patients will record their data in the span of 3 consecutive days, 2 
of which will be weekdays and 1 of which will be a weekend day.   
 Secondary variables include RLS status, serum ferritin levels, and ADHD 
symptom severity.  RLS status will be determined by a screening questionnaire that will 
be completed by parents or guardians for children under the age of 13 or independently 
by children over the age of 13. Those children whose screening questionnaire is positive 
 46 
for RLS will receive a formal diagnosis from a clinician using the IRLSSG criteria for 
definite or probable RLS.  One time fasting serum ferritin levels will be measured in 
ng/mL prior to initiation of the 3-day food diary. ADHD symptom severity will be 
measured using the Conners’ Parent Rating Scale.  A total scale score will be generated 
for each subject. 
 Confounding variables must also be identified and addressed in this study.  
Potential confounders include body mass index (BMI), race, parent education level, 
history of blood loss or heavy menses, stimulant use, and gastrointestinal absorption 
issues. These factors have the capability to influence the variables of this study, and 
therefore this information must be collected from each participant.  We will use the 
Intake Questionnaire as a way to measure these confounders.   
3.6 Data Collection 
 Study enrollment, data collection, and data analysis will begin in August 2016.  
Once we receive referrals from clinicians, potential participants will be contacted by 
phone in order to set up a screening appointment at their respective outpatient clinic.  
During this appointment, we will meet with patients to get the consent and assent forms 
signed. Research assistants will record demographic information and take anthropometric 
measurements of weight and height at this time. The Intake Questionnaire can be found 
in Appendix D.  Patients will then meet with a psychiatrist for a structured interview and 
verification of ADHD status as determined by the DSM-5 criteria. Patients and their 
parents will fill out the RLS questionnaire.  Parents of ADHD patients will also complete 
the Conners’ Parent Rating Scale. Lastly, blood collection will be obtained using 
venipuncture on the arms or hands of the patients. In addition to measuring serum ferritin, 
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a complete blood count (for hemoglobin, hematocrit, mean corpuscular volume, and red 
cell distribution width) and a full iron panel (for serum iron, transferrin, and total iron-
binding capacity) will also be obtained for possible use in future analyses. 6.5 ml of 
blood, 4 ml for a standard biochemistry tube and 2.5 ml for an EDTA tube, will be 
drawn. This sample will be taken after 8 hours of fasting.  
 At the end of the visit, a dietician will educate the patients and their parents or 
guardians on how to complete the 3-day food diary.  The dietician will give instruction on 
describing, measuring, and recording food intake.  This will include the use of common 
household measures and food models to estimate portion sizes.  As previously mentioned, 
participants will be asked to record in their diary for 3 consecutive days, 2 weekdays and 
1 weekend day. Children older than 8 will be able to fill out the diary on their own, but 
those younger will require the assistance of a parent or guardian.  A pre-paid, addressed 
envelope will be provided so that the diaries can be easily returned when the three-day 
period is over.  A dietician will analyze the data for daily iron intake using the Nutrition 
Data System for Research (NDSR) program.  Any additional debriefing or clarification 
needed will be done through a phone interview between the research assistant and the 
patient and/or parents.  
3.7 Sample Size Calculation 
 Our primary study hypothesis is that children with both ADHD and RLS are more 
likely to have a low serum ferritin and low daily dietary iron intake as compared to 
controls and those children with either disorder alone.  Given an expected prevalence of 
RLS of 44%, in a fixed sample size of 200 children with ADHD, around 88 of them 
should fit the criteria for RLS and 112 should not. We expect the difference in iron intake 
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between groups to be normally distributed with a standard deviation of ±5.8 mg. Using 
these values and Power and Precision V4 Software’s calculator (Biostat Inc., 2000, 
Englewood, NJ), a sensitivity analysis for a t-test of two independent samples with 
common variance showed that for a fixed sample size of 200 cases, we will be able to 
detect a mean difference in daily dietary iron intake of ±2.5 mg with at least 80% power 
and a two-tailed alpha level of 0.05.  We will require an equal number of controls given 
our matched study design, providing us with 400 subjects.  After accounting for 
confounders and an expected attrition rate of 7.5%, we will need a total of 490 
participants for our proposed study, 245 cases and 245 controls. As stated above, around 
600 children with an ADHD diagnosis attend the two designated outpatient clinics. 
Assuming that 50% of these patients meet the eligibility criteria and are interested in 
participating, we will be able to recruit our desired number of subjects.  Please see 
Appendix H for additional information regarding the sample size calculation. 
3.8 Analysis 
Data will be analyzed using SPSS for Windows statistical package version 19 
(SPSS Inc., Armonk, NY).  Numerical data will be expressed as means and standard 
deviations.  Categorical data will be expressed as frequencies and percentages.  Baseline 
characteristics and demographics will be obtained from the Intake Questionnaire given at 
the initial visit for descriptive analysis and to identify any possible confounders. Gender 
(male or female), stimulant medication (‘yes’ or ‘no’), family history of RLS (‘yes’ or 
‘no’), and menstruation status (‘yes’ or ‘no’) will be described as dichotomous variables 
and will be analyzed with a chi-square test. Race (White, Black or African American, 
Hispanic or Latino, Native American, Asian or Pacific Islander, Other) and parent 
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education level (less than high school, high school, beyond high school) will be described 
as nominal variables and will be analyzed with a Fisher’s Exact test. The income-to-
poverty ratio (<1, between 1 and 3, or >3) will be described as an ordinal variable and 
will be analyzed with a Kruskal-Wallis test. Age (in years) will undergo analysis of 
covariance (ANCOVA).  Lastly, the research assistant will collect the height and weight 
of each subject at the intake appointment and will calculate BMI as weight (in kg) 
divided by height (in meters).  BMI will be expressed as a percentile relative to 
standardized American growth charts. It will be described as an ordinal variable (<5% is 
underweight, 5-84% is healthy, 85-95% is overweight, and ≥ 95% is obese).  BMI will be 
analyzed with a Kruskal-Wallis test.  If any differences are found at baseline for these 
variables, they will be considered covariates and will be accounted for in later analyses.   
 The primary independent variable, ADHD, and the secondary variable of RLS 
will both be treated as dichotomous variables (‘yes’ or ‘no’). As stated above, the 
screening of RLS in the cases and controls will create four groups.  The primary predictor 
variable is mean daily iron intake measured in mg/day. This is a continuous variable that 
will be transformed into a dichotomous variable (low mean daily iron intake or high 
mean daily iron intake) using a median split.  Those patients whose mean daily iron 
intake is below the median for the distribution will be labeled with a diet low in iron and 
those above the median will be labeled with a diet high in iron. An odds ratio with 95% 
confidence intervals will be calculated for each of the 3 groups.  Chi-square tests will be 
used to analyze the association between disease status and iron intake, and any significant 
differences will warrant further Chi-square testing between groups. A Chi-square test will 
also be used to look at this association across all groups. The secondary variable of serum 
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ferritin level, measured in ng/mL, will also be described as a continuous variable that will 
be transformed into a dichotomous variable (low serum ferritin level or high serum 
ferritin level).  It will follow the same statistical procedure as outlined above for iron 
intake in order to examine the association between disease status and ferritin levels.  
ADHD symptom severity will be represented by the total score generated from the 
computerized Conners’ Scale.  It will be treated as a continuous variable.  
   To test the main hypothesis and look at the association between mean daily iron 
intake and serum ferritin level, Chi-square tests will again be performed within groups, 
between groups, and across all groups as part of the multivariate analysis.  We will then 
test for trend between the four groups.  Conditional logistic regression will be performed 
with a p<0.05 in order to account for possible confounding variables in the analysis. This 
will be done between the ADHD groups and controls, and then with a subgroup analysis 
between the two groups with ADHD. The final selection of confounding variables will be 
determined by the distribution of the study sample characteristics. Pearson correlation 
will be used to test correlation between mean dietary iron intake and ADHD symptom 
severity in each group.  
3.9 Timeline and Resources 
Our case-control study will occur within a 2-year period.  The proposal for the 
study will be submitted to the Pediatric Protocol Review Committee on June 1, 2016 and, 
after their authorization, to the HIC. We will allow 8 weeks for approval from the IRB.  
Consecutive enrollment of eligible participants will begin in August 2016 and will 
continue throughout the rest of this 2-year period.  Dieticians will continuously analyze 
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the food diaries as they are received for mean iron intake so that these data are ready for 
statistical testing when the study concludes in June 2018.  
In order to complete this study in the desired timeframe, we will assemble a 
research team that will work together at both site locations.  The Principal Investigator, 
Dr. Meir Kryger, and Co-Principal Investigator, Olivia Rojas, will oversee the study, 
manage the project’s finances and personnel, and ensure that it is conducted in 
compliance with laws and regulations.  We will hire two dieticians to educate patients on 
the correct use of the food diary and to analyze the diaries using the NDSR software.  We 
will also need a research assistant at each site to perform data collection, anthropometric 
measurements, and to assist the dieticians with follow-up of the food diaries.  Two 
phlebotomists will be hired to draw the blood specimens, and a statistician will help us to 
analyze the data.   
Each clinic site will provide an exam room with a computer for the initial intake 
visit and their respective laboratories will be used for specimen analysis.  Our office will 
be located in the Yale Child Study Center, and it will be equipped with a password-
protected computer on a secure server that will contain statistical software for data entry 
and analysis.  We will also have a locked cabinet for all paper records collected 
throughout the study.  All patients will receive compensation for parking at their intake 
visit and a pre-paid envelope in which to return their food diaries. 
 52 
CHAPTER 4: CONCLUSION 
4.1 Advantages and Disadvantages 
Some of the major advantages of our study lie in its case-control design.  We will be 
able to select for a large group of children with ADHD at the study outset without having 
to sample a large pediatric population.1 Although it is the most common psychiatric 
disorder in children, performing random sampling in a public school, for example, in 
order to find an adequate number of children with the disorder would require a much 
larger population size and much more recruitment time.  The use of the two outpatient 
clinics will allow us to quickly identify those children meeting inclusion criteria. Also, 
the sample of cases will not be exposed to considerable selection bias.2 We will recruit 
consecutive patients from a general ADHD visit, and we will not be selecting for sleep 
problems.  Therefore, our sample group will be representative of those children seen in a 
general pediatric psychiatric clinic.  
Secondly, we will be taking multiple steps to control for confounding variables.  We 
have proposed a matched design based on age, gender, and socioeconomic status in order 
to reduce variability and allow for comparability of dietary iron intake between the cases 
and controls.3 We expect age, gender, and socioeconomic status to be considerable 
confounding variables in this study, as all of these factors have been shown to influence 
the diet of children.  We also will adhere to the strict inclusion and exclusion criteria 
previously presented so that any association we find between diet and serum ferritin 
levels will not be distorted. We will further account for confounding variables specific to 
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the study sample at the end of data gathering. This includes statistical techniques 
previously mentioned that will be used for analysis.  
Next, we are using cost-effective tools to assist us in completing the study.  Subjects 
will complete questionnaires in order to evaluate ADHD symptom severity and to screen 
for RLS.  Dietary iron intake will be measured by a 3-day food diary that patients can 
easily return when complete.  These different measures allow for quick and efficient 
participation from each subject.  Furthermore, they are only expected to make one office 
visit for an initial assessment.  Because of the minimal time requirements, we expect a 
small attrition rate.  This will allow for more reliable and accurate results.   
Lastly, the proposed study will include a large sample size and a wide age range.  
Studies examining the association between serum ferritin levels, ADHD, and RLS 
mentioned in previous chapters often found differences that were not statistically 
significant.4-6 These studies were not fully powered, and therefore, skewed the result.  
Furthermore, many of the studies that laid the foundation for ours chose very narrow age 
ranges for inclusion of subjects.  Because we are including children from preschool 
through high school, our results will be more generalizable.  
One of the main disadvantages of this study is the potential for sampling bias when 
choosing controls.  We are proposing a convenience sample, as controls will be sampled 
in the same way as cases and from the same outpatient psychiatric clinics. While this is 
advantageous, it may reduce the external validity of the study.1 The children being 
considered the healthy control group may not be representative of healthy children out in 
the community.  This may likewise be true of the children with ADHD being seen in the 
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clinic as compared to those children with ADHD being treated by a primary care 
physician.3   
Another limitation of this study involves the chance of misreporting due to the use of 
the 3-day food diary. This is a self-reported method of measuring dietary intake, and, for 
this reason, there is a chance that participants could underestimate their portion sizes or 
energy intake.  This trend has been noted to increase with the age of the child.7 However, 
such errors in estimation have been documented to occur in other methods of dietary 
measure as well, including food frequency questionnaires, 24-hour recalls, and food 
diaries for other specified periods of time.8 In addition, we anticipate that errors will be 
evenly distributed in the four groups. Misreporting is something that is unavoidable when 
looking at diet and should not bias our result.  
Furthermore, it is possible that, given our calculated sample size, we will not have a 
large enough group of controls with RLS to make any statistically significant 
comparisons.  The prevalence of RLS in the general pediatric population is small, around 
2-4%, and so we expect a group of controls with RLS to be around 4 to 9 patients.9 Our 
proposed study may be underpowered to detect any significant difference between this 
group and another.  However, given that our primary hypothesis is most concerned with 
the group of children with comorbid ADHD and RLS, the lack of a group with RLS only 
will not skew our results regarding dietary iron intake. 
 Finally, we will not be able to detect causality between dietary iron intake and 
low serum ferritin levels.5 For this reason, our results must be interpreted with caution. 
We are interested in assessing the strength of the relationship between an exposure, 
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dietary iron intake, and disease, the disorders of ADHD and RLS.3 We will be able to 
calculate an odds ratio to determine the relative importance of this predictor variable in 
relation to the presence or absence of RLS and ADHD.1 
4.2 Clinical and Public Health Significance 
We expect to find an association between ADHD and RLS symptoms and the way 
in which children with both disorders eat.  If those children with the comorbid condition 
tend to have dietary behaviors that favor low iron foods, this information would have 
valuable implications for those providing care and possibly even prevention or 
progression in vulnerable populations.  As previously stated, overdiagnosis of ADHD has 
recently become a large concern in American society, and stimulant use has been on the 
rise.  Knowing the dietary factors putting children at risk for aggravation of their diseases 
would help health care providers give appropriate nutritional counseling to their pediatric 
patients.  It would also help providers to alleviate some of the symptoms that interfere 
with healthy daily functioning without—or with less—use of stimulant medication or 
iron supplementation.  This would simplify care for both the patients and their parents or 
guardians, while at the same time saving children from exposure to unnecessary 
medication.  In addition, it will further support the idea of routine serum ferritin level 
checks and RLS screening in the pediatric ADHD population.4,10,11   
Furthermore, by examining the serum ferritin levels of a large group of children 
with both ADHD and RLS, we will get a better sense of the role of iron supplementation 
in this population.  To the best of our knowledge, there have been no studies attempting 
to identify at what cut-off iron supplementation should begin in this population.  
Currently, studies suggest that children with serum ferritin below 75 ng/ml require iron 
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supplementation. If dietary iron intake and serum ferritin levels prove to be normal, this 
would suggest that there is a problem with transportation of iron from the periphery to the 
brain. If the diets of these children are adequately enriched with iron yet they still exhibit 
low serum ferritin levels, then this will suggest other pathophysiology occurring in the 
body, such as problems with gastrointestinal absorption. Advances in the understanding 
of how ADHD and RLS manifest will help to improve the quality of life of children 
suffering from these disorders.  
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APPENDIX A: PARENT CONSENT FORM 
PARENTAL PERMISSION FOR PARTICIPATION IN A RESEARCH PROJECT 
310 FR. 2 (2016-1) 
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN 
HOSPITAL 
UNIVERSITY OF CONNECTICUT HEALTH CENTER 
 
Study Title: Iron Intake in Children with Attention-Deficit/Hyperactivity Disorder and 
Restless Legs Syndrome 
Principal Investigators: Meir Kryger, MD, FRCPC and Olivia Rojas, PA-SII 
Funding Source: Yale Physician Associate Program 
 
Invitation to Participate and Description of Project 
 
We are inviting your child to participate in a research study designed to look at the 
relationship between dietary iron intake, serum ferritin levels, and restless legs syndrome 
(RLS) in children with attention-deficit/hyperactivity disorder (ADHD). Your child has 
been asked to participate because he/she is between the ages of 4-16 or may meet the 
criteria of ADHD.  Approximately 490 other children in New Haven and the surrounding 
area will be participating in the study.   
 
In order to decide whether or not you wish your child to be a part of this research 
study you should know enough about its risks and benefits to make an informed decision.  
This permission form gives you detailed information about the research study, which a 
member of the research team will discuss with you.  This discussion should go over all 
aspects of this research: its purpose, the procedures that will be performed, any risks of the 
procedures, and possible benefits. Once you understand the study, you will be asked if you 
wish your child to participate; if so, you will be asked to sign this form. 
 
Description of Procedures 
 
If you agree to your child participating in this study, your child will be asked to 
meet with a clinician in order to be weighed, measured, and evaluated for ADHD by a child 
psychiatrist through a short interview. While in the office, you and your child will be asked 
to fill out two short questionnaires, one regarding your child’s demographics and medical 
history, and the other regarding symptoms of RLS. You will be asked to provide your 
child’s ethnicity, your household income, and both parents’ education level. Additionally, 
your child will be asked to supply approximately one 6.5 ml fasting blood sample for 
analysis of serum ferritin level, which is a marker for blood iron stores, blood iron levels, 
and whether your child has anemia. Lastly, you and your child will be asked to complete a 
3-day food journal at home that you may send back through U.S. mail in order for us to 
determine how much iron your child consumes daily.  
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You will be told of any significant new findings that are developed during the 
course of your child’s participation in this study that may affect your willingness to 
continue to participate. 
 
Risks and Inconveniences 
 
Blood drawing is a relatively safe and short procedure, however there are risks. 
When drawing blood from the arm or hand, there is a possibility of temporary discomfort 
from the needle stick, bruising, redness, bleeding, or minor swelling at the site of the 
injection.  An infection or blood clot can develop at the site, however this is rare.  Some 
patients experience dizziness or lightheadedness when they give blood. Experienced nurses 




We may identify symptoms of ADHD or RLS in your child that you weren’t previously 
aware of but could be treated. Furthermore, what we learn about diet’s influence on ADHD 
and RLS may help improve the treatment regimen for other children suffering from these 




Any identifiable information that is obtained in connection with this study will 
remain confidential and will be disclosed only with your permission or as required by U.S. 
or State law.  Examples of information that we are legally required to disclose include 
abuse of a child or elderly person, or certain reportable diseases.  All information collected 
during the study will be de-identified.  A code number will be assigned to each participant 
that will be connected to their study data. Any paper documents will be locked in a file 
system, and any electronic information will be entered into password-protected computers 
on secure servers. When the results of the research are published or discussed in 
conferences, no information will be included that would reveal your child’s identity unless 
your specific permission for this activity is obtained.   
 
Representatives from Yale University, the Yale Human Research Protection 
Program and the Yale Human Investigation Committee (the committee that reviews, 
approves, and monitors research on human subjects) may inspect study records during 
internal auditing procedures.  However, these individuals are required to keep all 
information confidential.  
 
In Case of Injury 
 
If your child is injured while on study, seek treatment and contact the study doctor 
as soon as you are able.  Yale School of Medicine, Yale-New Haven Hospital, and the 
University of Connecticut Health Center do not provide funds for the treatment of 
research-related injury.  If your child is injured as a result of his or her participation in 
this study, treatment will be provided.  You or your insurance carrier will be expected to 
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pay the costs of this treatment.  No additional financial compensation for injury or lost 
wages is available. You do not give up any of your legal rights by signing this form. 
 
 
Voluntary Participation and Withdrawal 
 
You are free to choose not to have your child participate and if you do decide to 
have your child become a subject you are free to withdraw him/her from this study at any 
time during its course. Refusing to participate or withdrawing from the study will involve 
no penalty or loss of benefits to which your child is otherwise entitled. If your child decides 
not to participate or if you withdraw him/her, it will not harm you or your child’s 
relationship with your own doctors or with Yale-New Haven Hospital or the University of 
Connecticut Health Center. You can call the Co-Principal Investigator at (313) 310-1320 
and tell her that you no longer want to participate.  
 
The researchers may withdraw your child from participating in the research if 
necessary.  This includes if your child is diagnosed with a comorbid condition or if your 




We have used some technical terms in this form.  Please feel free to ask about 
anything you don't understand and to consider this research and the permission form 
carefully – as long as you feel is necessary – before you make a decision. 
 
Authorization and Permission 
 
I have read (or someone has read to me) this form and have decided to allow my child to 
participate in the project described above.  Its general purposes, the particulars of my 
child’s involvement and possible hazards and inconveniences have been explained to my 
satisfaction.  My signature also indicates that I have received a copy of this permission 
form. 
 
By signing this form, I give permission to the researchers to use and give out information 
about my child for the purposes described in this form.  By refusing to give permission, I 
understand that my child will not be able to be in this research.  
 
Name of Child: _____________________________
 
      
                                                       
 
Parent 1 Signature: ____________________          
Parent 2 Signature (if applicable): ____________________          
 
Date: ________________________                       Date: ________________________ 
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___________________________________________ ___________________ 
Signature of Person Obtaining Permission  Date 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the Co-Principal Investigator Olivia Rojas, PA-SII at (313) 310-1320. 
If after you have signed this form you have any questions about your privacy rights, 
please contact the Yale Privacy Officer at (203) 432-5919. 
 
If you would like to talk with someone other than the researchers to discuss problems, 
concerns, and questions you may have concerning this research, or to discuss your rights 
as a research subject, you may contact the Yale Human Investigation Committee at (203) 
785-4688.  
 
THIS FORM IS NOT VALID UNLESS THE FOLLOWING BOX HAS BEEN 

























APPENDIX B: PATIENT ASSENT FORM 
310 FR.1 
(2016-1) 
Child’s Assent for Being in a Research Study 
Yale-New Haven Hospital/Yale University School of Medicine 
University of Connecticut Health Center 
 
Title: Iron Intake in Children with Attention-Deficit/Hyperactivity Disorder and Restless 
Legs Syndrome 
 
Why am I here? 
 We are asking you to take part in a research study because we are trying to learn 
more about how a certain part of your food, a nutrient called iron, affects the amounts 
that are in your blood.  We also want to know how it affects your behavior. We are 
inviting you to be in the study because you are between the ages of 4-16 or may have a 
condition called attention-deficit/hyperactivity disorder, or ADHD. If you have ADHD, 
you might find it hard to focus and pay attention. 
 
Why are they doing this study? 
 We want to measure how much iron you are eating each day and see if this is similar 
to the amount that is found in your body. We also want to know if these amounts are related 
to certain behaviors that children show when they have ADHD. Another disease, called 
restless legs syndrome, can also be affected by iron.  We want to see how that illness is 
related, too.  
 
What will happen to me? 
 If you agree to be a part of this study, you will come to the office with your parents 
to meet with a doctor. The doctor will weigh and measure you, and also interview you to 
see if you have the disease called ADHD. While you are in the office, you and your parents 
will fill out two forms about your family and your behavior.  We will also collect 6.5 ml, 
or two small tubes, of blood so we can measure the amount of iron in it. Once you go home, 
you and your parents will keep a journal of all of the foods you eat for 3 days. You will 
send it back to us in the mail when you finish it.  
 
Will the study hurt? 
 We will be using a small needle to remove some of the blood from your arm or 
hand. This is will be a small amount that fits into a small tube. You may feel a pinch 
when we first begin taking your blood, and there may be some redness or bruising on 
your arm or hand afterwards. The nurses drawing your blood have done this many times 
before, and they will do their best to make you feel as little pain as possible. 
 
Will the study help me? 
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 We may find that what you are eating everyday has something to do with the 
amounts of iron in your body.  This may be causing you to have difficulty focusing or 
may cause you to have trouble falling asleep at night. If we find this out, we can help you 
with these problems. Also, you will be helping other children who may get ADHD in the 
future.   
 
What if I have any questions? 
 You can ask any questions that you have about the study. If you have a question 
later that you didn’t think of now, you can call me ((313) 310-1320) or ask me next time.  
 
Do my parents know about this? 
This study was explained to your parents and they said that you could be in it.  
You can talk this over with them before you decide. 
 
Do I have to be in the study? 
 You do not have to be in the study.  No one will be upset if you don’t want to do 
this.  If you don’t want to be in this study, you just have to tell them.  You can say yes now 
and change your mind later.  It's up to you. 
 
Writing your name on this page means that you agree to be in the study, and know what 
will happen to you.  If you decide to quit the study all you have to do is tell the person in 
charge. 
 
_________________________________________                  ___________________ 
Signature of Child       Date 
 
_________________________________________                  ___________________ 














APPENDIX C: ADOLESCENT ASSENT FORM 
ADOLESCENT ASSENT FOR PARTICIPATION IN A RESEARCH PROJECT 
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN 
HOSPITAL 
UNIVERSITY OF CONNECTICUT HEALTH CENTER 
310 FR 3 (2016-1) 
 
Study Title: Iron Intake in Children with Attention-Deficit/Hyperactivity Disorder and 
Restless Legs Syndrome 
Principal Investigators: Meir Kryger, MD, FRCPC and Olivia Rojas, PA-SII 
Funding Source: Yale Physician Associate Program 
 
Invitation to Participate and Description of Project 
 
You are invited to take part in a research study that will look at the relationship 
between dietary iron intake, serum ferritin levels, and restless legs syndrome (RLS) in 
children with attention-deficit/hyperactivity disorder (ADHD). You have been asked to 
take part because you are between the ages of 4-16 or may meet the criteria of ADHD.  
Approximately 490 other children in New Haven and the surrounding area will be 
participating in the study.   
 
In order to decide whether or not you wish to be a part of this research study, you 
should know enough about its risks and benefits to make an informed decision.  This assent 
form gives you detailed information about the study, which a member of the research team 
will discuss with you and your parents.  This discussion should go over all aspects of this 
research: its purpose, the procedures that will be performed, any risks of the procedures, 
and possible benefits. Once you understand the study, you will be asked if you wish to be 
in the study; if you do, you will be asked to sign this form. Your parents will also be asked 
to allow you to be in the study.  
 
Description of Procedures 
 
If you agree to be in this study, you will be asked to meet with a clinician in order 
to be weighed, measured, and evaluated for ADHD by a child psychiatrist through a short 
interview. While in the office, you and your parents will be asked to fill out two short 
questionnaires, one regarding your demographics and medical history, and the other 
regarding symptoms of restless legs syndrome. You will be asked to provide your ethnicity, 
your household income, and both of your parents’ education level. Additionally, you will 
be asked to supply approximately one 6.5 ml fasting blood sample for analysis of serum 
ferritin level, which is a marker for blood iron stores, blood iron levels, and whether you 
have anemia. Lastly, you will be asked to complete a 3-day food journal at home that you 




You and your parents will be told of any important new findings that are found 
while you are in this study that may change your decision about participating. 
 
Risks and Inconveniences 
 
Blood drawing is a relatively safe and short procedure, however there are risks. 
When drawing blood from the arm or hand, there is a possibility of temporary discomfort 
from the needle stick, bruising, redness, bleeding, or minor swelling at the site of the 
injection.  An infection or blood clot can develop at the site, however this is rare.  Some 
patients experience dizziness or lightheadedness when they give blood. Experienced nurses 




We may identify symptoms of ADHD or RLS that you weren’t previously aware of but 
could be treated. Furthermore, the things we learn about diet’s influence on ADHD and 
RLS may help improve the treatment regimen for other children suffering from these 
disorders in the future.  
 
Confidentiality and Privacy 
 
Any identifiable information that we obtain about you during this study will stay 
confidential and will be shared only if you agree to it.  There are also situations where we 
would have to release your identifiable information (your name for example) according to   
the U.S. or State law.  Examples of information that we have to report to authorities include 
abuse of a child, certain reportable diseases (such as being HIV positive or having Hepatitis 
B), or when we believe you may harm yourself or someone else. When the results of the 
research are published or discussed in conferences, no information will be included that 
would reveal your identity unless you allow us to do so. 
 
We understand that information about your health is personal, and we are 
committed to protecting the privacy of that information.  If you decide to be in this study, 
the researchers will get information that identifies you and your personal health 
information.  This may include information that might directly identify you, such as your 
name, date of birth, race, information from the intake questionnaire, and laboratory results 
from your blood sample.  This information will be de-identified as soon as possible, which 
means that we will replace your identifying information with a code. The principal 
investigator (the person who is responsible for this research) will keep a link that matches 
you to your coded information, and this link will be kept safe and available only to a few 
people on this research team.  
 
The information about your health that will be collected in this study includes:  
• Research study records 
• Medical and laboratory records of only those services provided in connection with 
this Study.   
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• The following information: age, gender, ethnic background, religion, parent 
information, past medical history, and medication history.  
  
Information about you and your health may be used by or given to:  
• The U.S. Department of Health and Human Services (DHHS) agencies. 
• Representatives from Yale Human Research Protection Program and the Yale 
Human Investigation Committee (the committee that reviews, approves, and 
monitors research on human subjects), who are responsible for ensuring 
research compliance.  These individuals are required to keep all information 
confidential.  
• Those providers who are participants in the Electronic Medical Record (EMR) 
system. 
• Those individuals at Yale who are responsible for the financial oversight of 
research including billings and payments. 
• The Principal Investigator: Meir Kryger, MD, FRCPC 
By signing this form, you let us use the information in the way we described above for this 
research study.   
 
The research staff at the Yale School of Medicine and the University of Connecticut 
Health Center have to obey the privacy laws and make sure that your information stays 
confidential.  Some of the people or agencies listed above may not have to obey those 
laws, which means that they do not have to protect the data in the same way we do. They 
could use or share your information in ways not mentioned in this form.  However, to 
better protect your health information, agreements are in place with these individuals 
and/or companies that require that they keep your information confidential.  
 
In Case of Injury 
 
If you are injured while on study, seek treatment and contact the study doctor as 
soon as you are able. Yale School of Medicine and the University of Connecticut Health 
Center do not provide funds for the treatment of research-related injury.  If you are 
injured as a result of your participation in this study, treatment will be provided.  Your 
parents or your insurance carrier will be expected to pay the costs of this treatment.  No 
additional financial compensation for injury or lost wages is available. You do not give 
up any of your legal rights by signing this form. 
 
Voluntary Participation and Withdrawal 
You do not have to take part in this study.  Refusing to participate will involve no 
penalty or loss of benefits to which you are otherwise entitled (such as your health care 
outside the study, the payment for your health care, and your health care benefits). Your 
health care outside the study will not change if you do not agree to participate.  However, 
you will not be able to enroll in this research study and will not receive study procedures 
as a study participant if you do not allow use of your information as part of this study. If 
you decide to take part in this study, and then change your mind, you can always stop and 
withdraw from this study at any time during its course. Withdrawing from the study will 
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involve no penalty or loss of benefits to which you are otherwise entitled.  It will not 
harm your relationship with your own doctors or with Yale-New Haven Hospital or the 
University of Connecticut Health Center.  
To stop your participation in the study, you can call a member of the research team at any 
time and tell them that you no longer want to take part.  If you stop participating in the 
study, the researchers will still be able to use the information that has already been collected 
about you. That information could also be given to others until the end of the research study, 
to make sure that the study produces valid results. 
 
The researchers may withdraw you from participating in the research if necessary.  This 
includes if you are diagnosed with a comorbid condition or if you exhibit non-compliance 




We have used some complicated terms in this form.  Please feel free to ask about 
anything you don't understand and to think about this research and the assent form carefully 
– as long as you need to – before you make a decision. We encourage that you talk to your 
family about your decision as well. If you come up with questions after reading this form, 
you can call me at (313) 310-1320. 
 
Authorization and Permission 
 
I have read (or someone has read to me) this form and have decided to participate in the 
project described above. Its general purposes, the things I will do in the study and possible 
risks and inconveniences have been explained to my satisfaction.  My signature also shows 
that I have been given a copy of this assent form. 
 
By signing this form, I give permission to the researchers to use and give out information 
about me for the reasons described in this form.  If I decide not to give permission, I 
understand that I will not be able to be in this research.  
 
Name of Subject: _____________________________
 
      





   
___________________________________________ ___________________ 
Signature of Person Obtaining Assent  Date 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the Co- Principal Investigator Olivia Rojas, PA-SII at (313) 310-1320.  
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If you would like to talk with someone other than the researchers to discuss problems, 
concerns, and questions you may have concerning this research, or to discuss your rights 
as a research subject, you may contact the Yale Human Investigation Committee at (203) 
785-4688. If after you have signed this form you have any questions about your privacy 
rights, please contact the Yale Privacy Officer at (203) 432-5919. 
 






Gender (Circle One):  Male    or     Female 
 
Ethnicity:    White             Black or African American 
     Hispanic or Latino           Asian or Pacific Islander 
     Native American            Other 
 
Total Household Income: _____________________________ 
 
Parent Education Level: Father:               Mother: 
 Less than high school  Less than high school 
     High school   High school 
     Beyond high school  Beyond high school 
 
Have you ever been diagnosed with RLS?  Yes        No 
 
If yes, and you are currently being treated, please provide the name, dose,  
 
and frequency of medication: __________________________________________ 
 
Is there a family history of RLS?  Yes  No        If yes, who? ________________ 
 
Do you currently have an infection:  Yes        No 
 
Have you had an infection in the past month?   Yes  No 
 
Do you have a history of psychiatric issues?   Yes  No 
 
If yes, explain: _____________________________________________________ 
 
Do you currently use cigarettes, alcohol, or any illicit drugs?  Yes      No 
 





Do you have a history of gastrointestinal disorders, such as celiac disease, Crohn’s 
disease, ulcerative colitis, or chronic diarrhea?   Yes  No 
 
If yes, explain: _____________________________________________________ 
 
If you are female, have you begun menstruating?   Yes    No  
 
If yes, when was your last menstrual period? ____________________________ 
 
 
Are you currently using medication for your ADHD?   Yes         No         N/A 
 




Are you currently using iron supplementation?   Yes  No 
 














APPENDIX E: RLS QUESTIONNAIRE FOR PARENTS 
Screening Questionnaire: 
Restless Legs Syndrome 
(Parent Version) 
 
Child’s Name:  ____________________________________ 
 
Person filling out form:  _____________________________ 
 
1. Does your child ever have “growing pains”? (Check One) 
 
_______ never   _______ occasionally   _______ sometimes   _______ frequently 
   (less than 1x/month)           (1-2x/month)       (1-2x/wk to daily) 
 
2. Does your child complain of uncomfortable or funny feelings (creeping, crawling, 
    tingling) in his/her legs? (Check One) 
 
_______ never   _______ occasionally   _______ sometimes   _______ frequently 
        (less than 1x/month)          (1-2x/month)       (1-2x/wk to daily) 
 
 
          YES                 NO           DON’T KNOW 
3. Does your child:      
 
A. Notice funny feelings in his/her legs 
     (or do they seem worse) when lying  
     down or sitting?                 ______            ______               ______ 
 
B. Have partial relief with movement 
     (wiggling feet, toes, or walking?)    ______            ______       ______ 
 
 
C. Complain that the feelings are worse 
     at night?       ______    ______               ______ 
 
D. Have a lot of fidgeting or wiggling of  
     the toes or legs or the whole body while 
     sleeping?        ______    ______       ______ 
 
 
4. Does your child appear restless while sleeping (thrashing around, banging feet against 
    wall, twisting covers, or falling out of bed)?  (Check One) 
 
_______ never   _______ occasionally   _______ sometimes   _______ frequently 
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        (less than 1x/month)           (1-2x/month)       (1-2x/wk to daily) 
 
 
5. Does your child seem more restless, fidgety or hyperactive than most children his/her 
    age? 
 
_______ never   _______ occasionally   _______ sometimes   _______ frequently 
        (less than 1x/month)           (1-2x/month)       (1-2x/wk to daily) 
 
6a. Has anyone in the family (including grandparents, aunts/uncles) been diagnosed with 
      restless legs or periodic leg movements during sleep? ______Yes ______No 
 
If so, who: _______________________ 
 
6b. Does anyone in the family have several problems falling or staying asleep? 
 If so, who: ____________________. Type of problem, if known: ________________ 
 
7. How often, on average, does your child consume caffeine-containing beverages or 
    food? (coffee, tea, cola beverages, chocolate) 
 
_______ never   _______ occasionally   _______ sometimes   _______ frequently 
        (less than 1x/month)           (1-2x/month)       (1-2x/wk to daily) 
 
8. Has your child ever been diagnosed and/or treated for anemia? 
 
Yes_____  No______  Don’t Know______ 













Mindell JA & Owens JA. A Clinical Guide to Pediatric Sleep: Diagnosis and 
Management of Sleep Problems. Philadelphia: Lippincott Williams & Wilkins. 2015. 
APPENDIX F: RLS QUESTIONNAIRE FOR ADOLESCENTS 
Screening Questionnaire: 
Restless Legs Syndrome 
(Adolescent Self-Report Version) 
 
Your name: _____________________________________________________________ 
 
1.   Have you ever had “growing pains”? (Check one) 
 
____ never  ____ occasionally  ____ sometimes  ____ frequently  ____ only in the past  
            (less than 1x/month)    (1-2x/month)     (1-2x/wk to daily) 
 
2.   Do you have uncomfortable or funny feelings (creeping, crawling, tingling) in your 
legs? (Check one) 
 
____ never  ____ occasionally  ____ sometimes  ____ frequently  ____ only in the past  
            (less than 1x/month)   (1-2x/month)     (1-2x/wk to daily) 
 
3.   Do you ever: 
 
                               YES         NO         DON’T KNOW 
 
A. Notice funny feelings in your legs (or do               ☐       ☐          
☐    
they seem worse) when lying down or sitting? 
 
B. Have partial relief with movement (wiggling         ☐       ☐          
☐    
feet, toes or walking?)  
 
C. Notice that the feeling is worse at night?                ☐       ☐          
☐                
 
D. Have a lot of fidgeting or wiggling of your feet     ☐       ☐          
☐      
or toes when sitting or lying down? 
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E. Have repeated jerking movements in toes or          ☐       ☐          
☐           
legs or the whole body while sleeping?  
 
 
Mindell JA & Owens JA. A Clinical Guide to Pediatric Sleep: Diagnosis and 
Management of Sleep Problems. Philadelphia: Lippincott Williams & Wilkins. 2015. 
 
APPENDIX G: SAMPLE PAGE FROM 3-DAY FOOD DIARY 
Directions: Please complete this diary for 3 consecutive days, including one weekend 
day. Record all food and drinks you consume as soon as possible after eating. For each 
item you consume, indicate the serving size, the method of preparation, and any added 
condiments you may use.  List brands and restaurant names when applicable.  
Date: _________________________________ 
SELECT ONE:  WEEKDAY    or      WEEKEND DAY 


















Dinner                                                                                    Time: 
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APPENDIX H: SAMPLE SIZE CALCULATION 
The sample size for the proposed study will be based off of the results of the 
studies done by Konofal et al. and Durá Travé et al.1,2 Because our study will be case-
controlled, a fixed sample size will be used. In order to determine a sufficient size, the 
expected prevalence of RLS will be 44%. We will include those with either a “definite” 
or “probable” RLS diagnosis. Multiple studies have explored the prevalence of RLS in 
the ADHD population, however each study used different criteria when diagnosing RLS 
and RLS symptoms. Because the IRLSSG criteria are the standard and most rigorous, the 
two studies that used IRLSSG guidelines were considered to determine sample size.  As 
previously discussed the study done in 2003 by Konofal et al. found a 44% prevalence for 
“definite” or “probable” RLS in a group of children with ADHD.1 In 2014, Kwon et al. 
conducted a cross-sectional study to determine RLS prevalence in children with ADHD, 
and 7.2% of subjects were diagnosed with “definite” or “probable” RLS.3 However, this 
study had a small sample size, no control group, and did not exclude the influence of drug 
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therapy as Konofal et al. did. In a fixed sample of 200 children with ADHD, 88 should fit 
the criteria for RLS. 
We will also use the study done by Durá Travé to determine standard deviation 
and effect size of the proposed study.2 This study assessed dietary iron intake in children 
with ADHD and found results similar to what we are hypothesizing.  Energin et al. also 
found results fitting our hypothesis, but stratified their results by gender.4 Furthermore, 
there were no studies examining dietary iron intake in RLS patients, and for this reason 
intake as related to RLS cannot be taken into account when determining sample size.  
Using Durá Travé’s study, we expect each group’s iron intake to be normally distributed 
with a standard deviation of ±5.8 mg.2 They were able to detect an effect size of 3.8 mg 
between ADHD and a healthy control group.  Because the proposed study is comparing 
iron intake of children with the comorbid condition with that of children with each 
disease alone, a smaller effect size is expected and will be estimated in order to power the 
study adequately. Therefore, with 200 ADHD patients, we will be able to detect a 
difference in daily iron ingestion of 2.5 mg with a power of 80%.   
Lastly, we will gather an equal number of controls without ADHD, or 200 
children, and adjust for losses to follow-up and for confounding variables.  In 
Donfrancesco et al.’s case control study examining the relationship between serum 
ferritin and ADHD, an attrition rate of 7.5% was determined.5 To correct for 
confounding, we will add 10 people to each group for every secondary variable that we 
are comparing.  Accounting for all of this will bring us to a total of 490 participants (245 
with ADHD and 245 controls without ADHD). 
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